In a study that sought to identify common genetic variants in families with more than one member with a diagnosis of multiple sclerosis (MS), researchers from the University of British Columbia...
Scientists have discovered that a special type of cell is much more prolific in generating a protective sheath covering nerve fibres than previously believed.
The revelation about Schwann cells...
Results from Expand, a phase III study, have revealed that treatment with siponimod (Mayzent) led to significant improvement in cognitive processing speed in patients with secondary progressive...
New research conducted by the University of Edinburgh has reconfirmed that Scotland has one of the highest rates of multiple sclerosis (MS) in the world.
Using the Scottish Multiple Sclerosis...
Those with less visible disabilities are set to benefit from the biggest change in the Blue Badge scheme in 50 years. As of the 15 June 2019 new guidance on Blue Badge parking permits has been rolled...
An international team of researchers led by the University of British Columbia (UBC) has made a scientific advance they hope will lead to the development of preventative treatments for multiple...
Obesity is an aggravating factor in relapsing remitting multiple sclerosis (RRMS). A recent study by the Unit of Neurology and Neurorehabilitation of the Italian Ministry of Health as a Clinical...
Eleven-year-old Asher Walton-Mitchell from Sheffield has raised more than £1,300 after writing to 400 neighbours and asking them for help. Asher's neighbour Phil Waterworth, a former teacher who has...
Simvastatin, a widely prescribed cholesterol lowering drug, may slow brain atrophy and disease progression in secondary progressive multiple sclerosis (SPMS) for reasons unrelated to changes in blood...
Alterations in the composition of microbes in the gut may influence childhood MS. That’s according to research carried out by Dr. Helen Tremlett, PhD, of the University of British Columbia in Canada...
